A187660 logo

Hyundai ADM Bio Inc. Stock Price

KOSDAQ:A187660 Community·₩996.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A187660 Share Price Performance

₩18,200.00
16387.00 (903.86%)
₩18,200.00
16387.00 (903.86%)
Price ₩18,200.00

A187660 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk with imperfect balance sheet.

4 Risks
0 Rewards

Hyundai ADM Bio Inc. Key Details

₩9.7b

Revenue

₩9.7b

Cost of Revenue

₩58.0m

Gross Profit

₩18.0b

Other Expenses

-₩17.9b

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
-327.39
0.59%
-183.98%
124.4%
View Full Analysis

About A187660

Founded
2003
Employees
160
CEO
Hyun-woo Kim
WebsiteView website
hdadmbio.com

Hyundai ADM Bio Inc., a contract research organization, provides clinical services in Asia. It offers clinical development services, such as medical writing, clinical operation, late phase study, data management, biostatistics, and regulatory affairs. The company also provides pharmacovigilance services, which include case processing and safety reporting, safety and risk management plans, aggregate reporting, literature screening, and medical device vigilance; and quality assurance services. In addition, it develops, manufactures, and sells medical microneedle patches. The company was formerly known as ADM Korea Inc. and changed its name to Hyundai ADM Bio Inc. in September 2024. Hyundai ADM Bio Inc. was founded in 2003 and is headquartered in Seoul, South Korea.

Recent A187660 News & Updates

Recent updates

No updates